260 related articles for article (PubMed ID: 15548159)
1. GnRH antagonists in poor responders.
Kolibianakis E; Albano C; Zikopoulos K; Kahn JA; Van Steirteghem A; Devroey P
Acta Obstet Gynecol Scand; 2004 Dec; 83(12):1216-7. PubMed ID: 15548159
[No Abstract] [Full Text] [Related]
2. Comparison of mild and microdose GnRH agonist flare protocols on IVF outcome in poor responders.
Karimzadeh MA; Mashayekhy M; Mohammadian F; Moghaddam FM
Arch Gynecol Obstet; 2011 May; 283(5):1159-64. PubMed ID: 21221982
[TBL] [Abstract][Full Text] [Related]
3. Ultrashort gonadotropin-releasing hormone agonist combined with flexible multidose gonadotropin-releasing hormone antagonist for poor responders in in vitro fertilization/embryo transfer programs.
Orvieto R; Kruchkovich J; Rabinson J; Zohav E; Anteby EY; Meltcer S
Fertil Steril; 2008 Jul; 90(1):228-30. PubMed ID: 17681292
[TBL] [Abstract][Full Text] [Related]
4. Controlled ovarian stimulation using a long gonadotropin-releasing hormone antagonist protocol: a proof of concept and feasibility study.
Weissman A; Ravhon A; Steinfeld Z; Nahum H; Golan A; Levran D
Gynecol Obstet Invest; 2013; 76(2):113-8. PubMed ID: 23920048
[TBL] [Abstract][Full Text] [Related]
5. Microdose gonadotropin-releasing hormone agonist flare-up protocol versus multiple dose gonadotropin-releasing hormone antagonist protocol in poor responders undergoing intracytoplasmic sperm injection-embryo transfer cycle.
Kahraman K; Berker B; Atabekoglu CS; Sonmezer M; Cetinkaya E; Aytac R; Satiroglu H
Fertil Steril; 2009 Jun; 91(6):2437-44. PubMed ID: 18555238
[TBL] [Abstract][Full Text] [Related]
6. GnRH antagonist rescue of a long-protocol IVF cycle and GnRH agonist trigger to avoid ovarian hyperstimulation syndrome: three case reports.
Martínez F; Rodríguez DB; Buxaderas R; Tur R; Mancini F; Coroleu B
Fertil Steril; 2011 Jun; 95(7):2432.e17-9. PubMed ID: 21513932
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of high initial daily doses of gonadotropin in patients with poor ovarian reserve.
Chou LL; Hwu YM; Lin MH; Lin SY; Lee RK
Taiwan J Obstet Gynecol; 2010 Dec; 49(4):442-8. PubMed ID: 21199746
[TBL] [Abstract][Full Text] [Related]
8. GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study.
Humaidan P; Bredkjaer HE; Bungum L; Bungum M; Grøndahl ML; Westergaard L; Andersen CY
Hum Reprod; 2005 May; 20(5):1213-20. PubMed ID: 15760966
[TBL] [Abstract][Full Text] [Related]
9. Comparison between "short" and "long" protocols in an ICSI programme.
Loutradis D; Stefanidis K; Drakakis P; El Sheikh A; Milingos S; Antsaklis A; Michalas S
Eur J Obstet Gynecol Reprod Biol; 2005 May; 120(1):69-72. PubMed ID: 15866089
[TBL] [Abstract][Full Text] [Related]
10. Management of poor responders: can outcomes be improved with a novel gonadotropin-releasing hormone antagonist/letrozole protocol?
Schoolcraft WB; Surrey ES; Minjarez DA; Stevens JM; Gardner DK
Fertil Steril; 2008 Jan; 89(1):151-6. PubMed ID: 17482177
[TBL] [Abstract][Full Text] [Related]
11. Gonadotropin-releasing hormone agonist combined with a reduced dose of human chorionic gonadotropin for final oocyte maturation in fresh autologous cycles of in vitro fertilization.
Shapiro BS; Daneshmand ST; Garner FC; Aguirre M; Thomas S
Fertil Steril; 2008 Jul; 90(1):231-3. PubMed ID: 17981269
[TBL] [Abstract][Full Text] [Related]
12. Luteal-phase ovarian stimulation is a feasible method for poor ovarian responders undergoing in vitro fertilization/intracytoplasmic sperm injection-embryo transfer treatment compared to a GnRH antagonist protocol: A retrospective study.
Wei LH; Ma WH; Tang N; Wei JH
Taiwan J Obstet Gynecol; 2016 Feb; 55(1):50-4. PubMed ID: 26927248
[TBL] [Abstract][Full Text] [Related]
13. Impact of luteinizing hormone administration on gonadotropin-releasing hormone antagonist cycles: an age-adjusted analysis.
Bosch E; Labarta E; Crespo J; Simón C; Remohí J; Pellicer A
Fertil Steril; 2011 Mar; 95(3):1031-6. PubMed ID: 21067717
[TBL] [Abstract][Full Text] [Related]
14. Comparison of protocols efficacy in poor responders: differences in oocytes/embryos competence with different protocols, a retrospective study.
Manno M; Tomei F; Cervi M; Favretti C; Adamo V
Fertil Steril; 2009 Apr; 91(4 Suppl):1431-3. PubMed ID: 18706554
[TBL] [Abstract][Full Text] [Related]
15. Microdose flare versus antagonist for poor responders.
Meldrum DR; Schoolcraft W
Fertil Steril; 2010 May; 93(7):e35; author reply e36. PubMed ID: 20303479
[No Abstract] [Full Text] [Related]
16. [In vitro fertilization and embryo transfer].
Saito H; Nakagawa K; Kojima R; Takahashi Y
Nihon Rinsho; 2006 Apr; 64 Suppl 4():80-4. PubMed ID: 16689289
[No Abstract] [Full Text] [Related]
17. [Differing response to GnRH antagonists in cycles of ovarian hyperstimulation plus intrauterine insemination].
Barros-Delgadillo JC; Trejo-Castañeda H; E-Ormsby C; Gaviño-Gaviño F
Ginecol Obstet Mex; 2010 Jan; 78(1):15-28. PubMed ID: 20931799
[TBL] [Abstract][Full Text] [Related]
18. Progesterone rise on the day of human chorionic gonadotropin administration impairs pregnancy outcome in day 3 single-embryo transfer, while has no effect on day 5 single blastocyst transfer.
Papanikolaou EG; Kolibianakis EM; Pozzobon C; Tank P; Tournaye H; Bourgain C; Van Steirteghem A; Devroey P
Fertil Steril; 2009 Mar; 91(3):949-52. PubMed ID: 17555751
[TBL] [Abstract][Full Text] [Related]
19. Gonadotropin-releasing hormone antagonist versus progestin for the prevention of premature luteinising hormone surges in poor responders undergoing in vitro fertilisation treatment: study protocol for a randomised controlled trial.
Wang Y; Kuang Y; Chen Q; Cai R
Trials; 2018 Aug; 19(1):455. PubMed ID: 30134964
[TBL] [Abstract][Full Text] [Related]
20. Follicular recruitment is reduced in minimal stimulation for controlled ovarian hyperstimulation using purified human menopausal gonadotropin compared with follicle-stimulating hormone.
Park JK; Clark R; Session DR
Fertil Steril; 2009 Apr; 91(4 Suppl):1434-6. PubMed ID: 18701097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
